✦ LIBER ✦

Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma

✍ Scribed by Nalan Gokgoz; Jay S. Wunder; Spyro Mousses; Sasha Eskandarian; Robert S. Bell; Irene L. Andrulis

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 153 KB
Volume: 92
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20011015)92:8<2181::aid-cncr1561>3.0.co;2-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correlation of c-fos, p53, and PCNA expr

Correlation of c-fos, p53, and PCNA expression with treatment outcome in osteosarcoma

✍ Kakar, Sanjay; Mihalov, Michael; Chachlani, Naresh A.; Ghosh, Luna; Johnstone, H 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

p53 and MDM2 alterations in osteosarcoma

p53 and MDM2 alterations in osteosarcomas : Correlation with clinicopathologic features and proliferative rate

✍ Fulvio Lonardo; Takafumi Ueda; Andrew G. Huvos; John Healey; Marc Ladanyi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

was not associated with a higher proliferative rate. The mean age of patients with York. p53 positive OS (40 years) was older than that of the p53 negative group (28 years) (P õ 0.04). Furthermore, three of the four cases of OS arising in Paget's disease

Overexpression and mutations of p53 in m

Overexpression and mutations of p53 in metastatic malignant melanomas

✍ Arndt Hartmann; Hagen Blaszyk; Julie S. Cunningham; Renee M. McGovern; Jennifer 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 495 KB 👁 2 views

Alterations of the p53 tumor suppressor gene are the most frequent genetic abnormalities in human malignancies, but the role of p53 in the etiology of malignant melanomas is unclear. Fifty unselected malignant melanomas were analyzed for p53 overexpression by immunohistochemistry using 3 monoclonal

Emergence of secondary acute leukemia in

Emergence of secondary acute leukemia in a patient treated for osteosarcoma: implications of germline TP53 mutations

✍ Panizo, Carlos; Patiño, Ana; Calasanz, José; Rifón, José; Sierrasesumaga, Luis; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

Background. Secondary leukemia and myelodysplastic syndromes have been reported in patients following treatment for a wide range of neoplastic disorders. However, second malignancies after chemotherapy and/or irradiation for osteosarcoma are unusual. Procedure. We report the case of a 15-yearold gi

Reproductive functions in female patient

Reproductive functions in female patients treated with adjuvant and neoadjuvant chemotherapy for localized osteosarcoma of the extremity

✍ Alessandra Longhi; Eleonora Porcu; Simone Petracchi; Michela Versari; Lucia Cont 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

The side effects of chemotherapy on ovarian and reproductive functions in female patients who received adjuvant and/or neoadjuvant treatment for localized osteosarcoma of the extremities at our institution in the last 21 years (1974 -1995) were assessed. ## METHODS. Ninety-two patients with a mea

Abnormal p53 expression is rare in clini

Abnormal p53 expression is rare in clinically localized human prostate cancer: Comparison between immunohistochemical and molecular detection of p53 mutations

✍ Mottaz, Alain E.; Markwalder, Regula; Fey, Martin F.; Klima, Irena; Merz, Vincen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 1 views

## BACKGROUND. We assessed the frequency and molecular basis of p53 mutations in clinically localized prostatic adenocarcinoma. METHODS. Prostate specimens were examined from 100 patients with clinically localized prostatic adenocarcinoma and 13 patients with benign prostatic hyperplasia (BPH). Mu